EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Early Identification and Prognostic Stratification of Cancer Cachexia Using Explainable Machine Learning: A Multicentre Cohort Study

Wei Huang, Kan Pan, Mingjian Zhao, Tingting Zhao, Nuo Xu, Hanping Shi iD

Journal of Cachexia, Sarcopenia and Muscle · 2026

DOI: 10.1002/jcsm.70370 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Wei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Nutrition and Department of Colorectal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang,…. Hauptthemen laut MEDLINE: Cachexia, Machine Learning, Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer cachexia is a heterogeneous syndrome that remains frequently underrecognized in routine oncology care, especially before overt wasting develops. We aimed to develop and externally validate an explainable two‐stage machine learning framework for early cachexia identification and prognostic stratification using routinely available clinical data.

Methods

In this multicentre real‐world study based on the INSCOC registry, 10 796 hospitalized adults with cancer were analysed, including 3995 patients with cachexia and 6801 without cachexia. First‐stage machine learning models were trained separately in high‐ and low‐prevalence settings to identify cachexia. Second‐stage survival models were developed in 1711 cachexia patients with follow‐up data from a 5172‐patient follow‐up cohort. A total of 586 deaths were observed in the cachexia follow‐up cohort. External validation used an independent Fujian cohort of 886 patients.

Results

Cachexia prevalence was 37.0% (3995/10 796). Compared with non‐cachexia patients, cachexia patients had lower median BMI (21.0 vs. 23.4 kg/m2), albumin (37.9 vs. 39.7 g/L), triceps skinfold thickness (13.0 vs. 16.0 mm), calf circumference (33.0 vs. 35.0 cm) and higher CRP (5.9 vs. 3.9 mg/L); all p < 0.001. For cachexia identification, XGBoost achieved the best discrimination, with an AUC of 0.867 (95% CI: 0.857–0.878), sensitivity 0.706 and specificity 0.846 in the high‐prevalence group, and an AUC of 0.870 (95% CI: 0.861–0.880), sensitivity 0.817 and specificity 0.756 in the low‐prevalence group. In external validation, the AUCs were 0.744 in the high‐prevalence subgroup and 0.694 in the low‐prevalence subgroup. Among cachexia patients with follow‐up, the 1‐year mortality rate was 20.8% (95% CI: 19.0%–22.9%). For prognostic stratification, the random survival forest model showed the most favourable overall performance, with a C‐index of 0.680 and time‐dependent AUCs of 0.800, 0.777, 0.741 and 0.716 at 3, 6, 9 and 12 months, respectively. Advanced TNM stage and higher CRP were associated with worse survival, whereas higher albumin, prealbumin and HDL were associated with better survival.

Conclusions

This explainable two‐stage framework enables accurate cachexia identification across different prevalence settings and clinically meaningful prognostic stratification in patients with established cachexia. Using routine variables and independent external validation, it provides a practical basis for earlier recognition, risk‐adapted supportive care and precision management in oncology practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaMachine LearningNeoplasmsAgedFemaleHumansMaleMiddle AgedCohort StudiesPredictive Learning ModelsPrognosis

Stichwörter der Autor:innen

cancer cachexiaexplainable artificial intelligencemachine learningprognostic stratificationreal‐world datasurvival prediction

Autor:innen und Institutionen

  • Institute of Clinical Nutrition and Department of Colorectal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • The First School of Medicine and School of Information and Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
  • Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Key Laboratory of Cancer Foods for Special Medical Purpose (FSMP) for State Market Regulation, Beijing, China.
  • Department of Gastrointestinal and Gland Surgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.

ORCID-Profile: Hanping Shi

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Huang, W., Pan, K., Zhao, M., Zhao, T., Xu, N., & Shi, H. (2026). Early Identification and Prognostic Stratification of Cancer Cachexia Using Explainable Machine Learning: A Multicentre Cohort Study. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70370

Vancouver

Huang W, Pan K, Zhao M, Zhao T, Xu N, Shi H. Early Identification and Prognostic Stratification of Cancer Cachexia Using Explainable Machine Learning: A Multicentre Cohort Study. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70370

BibTeX
@article{Huang2026,
  author = {Huang, Wei and Pan, Kan and Zhao, Mingjian and Zhao, Tingting and Xu, Nuo and Shi, Hanping},
  title = {Early Identification and Prognostic Stratification of Cancer Cachexia Using Explainable Machine Learning: A Multicentre Cohort Study},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  doi = {10.1002/jcsm.70370}
}
Kostenlos starten →